Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: A phase II trial

Levi S. Downs, Justin C. Chura, Peter A. Argenta, Patricia L. Judson, Rahel Ghebre, Melissa A. Geller, Linda F. Carson

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: A phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences